Učitavanje...

Csnk1a1 inhibition has p53-dependent therapeutic efficacy in acute myeloid leukemia

Despite extensive insights into the underlying genetics and biology of acute myeloid leukemia (AML), overall survival remains poor and new therapies are needed. We found that casein kinase 1 α (Csnk1a1), a serine-threonine kinase, is essential for AML cell survival in vivo. Normal hematopoietic stem...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Järås, Marcus, Miller, Peter G., Chu, Lisa P., Puram, Rishi V., Fink, Emma C., Schneider, Rebekka K., Al-Shahrour, Fatima, Peña, Pablo, Breyfogle, L. Jordan, Hartwell, Kimberly A., McConkey, Marie E., Cowley, Glenn S., Root, David E., Kharas, Michael G., Mullally, Ann, Ebert, Benjamin L.
Format: Artigo
Jezik:Inglês
Izdano: The Rockefeller University Press 2014
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3978274/
https://ncbi.nlm.nih.gov/pubmed/24616378
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1084/jem.20131033
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!